Airtonics Health
COVID-19 Therapy
Company Overview
Snapshot
Founded in July 2020 by Oron Zachar, Airtonics Health operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its technology. In May 2020, the company's research project on COVID-19 therapy using nanosilver gained a strategic partner, ITP-System.
Business overview
Airtonics Health specializes in developing a minimally invasive method for inactivating the SARS-CoV-2 coronavirus at an early stage of infection. The company leverages nanosilver with specific physicochemical parameters to achieve this. Operating within the Health Tech & Life Sciences sector, particularly in Medical Devices and Medical Treatment & Therapeutics, Airtonics Health targets healthcare providers and patients with its therapeutic solutions.
Strategic signal
In May 2020, Airtonics Health's international research project on COVID-19 therapy, utilizing nanosilver, secured ITP-System as a strategic partner. This collaboration signals external validation for Airtonics Health's innovative approach to combating SARS-CoV-2 and highlights its potential to advance therapeutic options in the health tech and life sciences market.
Log in to access full profile ›Company Intelligence Q&A
- What is Airtonics Health's primary focus?
- Airtonics Health focuses on developing a minimally invasive method to inactivate the SARS-CoV-2 coronavirus at an early stage of infection, utilizing nanosilver with specific physicochemical parameters.
- When was Airtonics Health founded?
- Airtonics Health was founded in July 2020.
- Who is the founder of Airtonics Health?
- Oron Zachar is the founder of Airtonics Health.
- What was a significant partnership for Airtonics Health?
- In May 2020, ITP-System became a partner in Airtonics Health's international research project focused on COVID-19 therapy using nanosilver.
- What is the current status of Airtonics Health?
- Airtonics Health is currently Non Active, having ceased to operate in August 2025.